VGX-57545-26971
3 vaccinations
2 coded responses
38 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 625 / IL
- Registered
- 2021-02-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
5AN-23870-34709
Child or adolescent in my care · Male · 2022-07-06
FGM-15319-00478
Child or adolescent in my care · Male · 2022-07-06
DSL-26531-11166
Child or adolescent in my care · Female · 2022-08-09
Timeline
-
2021-02-10
Registered in v-safe
-
2021-02-10
Dose 1 — Pfizer-BioNTech
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-17
- 2021-02-24
-
2021-03-03
Dose 2 — Pfizer-BioNTech
- 2021-03-03
-
2021-03-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-03-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling, Itching · NoneAdult check-in
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling, Itching · NoneAdult check-in
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-06-02
-
2021-09-03
Survey response — 6 months, dose 2MedDRA: Pre-existing disease — Feeling: Good · Be unable to work or attend schoolFree text: When I had COVID - Fatigue, congestion/runny nose, coughMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-19
Dose 3 — Pfizer-BioNTech
- 2021-11-19
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-11-21
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-12-05
- 2021-12-10
- 2021-12-19
- 2021-12-24
-
2021-12-31
Survey response — day 42, dose 3MedDRA: Nasal congestion, Oropharyngeal pain, Rhinorrhoea — Feeling: PoorFree text: Sore throat, runny/congested noseMedDRA releases: 2024-11 · check-in free text available
- 2022-02-18
- 2022-05-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-10 | Pfizer-BioNTech | |
| 2 | 2021-03-03 | Pfizer-BioNTech | |
| 3 | 2021-11-19 | Pfizer-BioNTech | No |
Free text
Release 9 — 6 months, dose 2
Symptoms: When I had COVID - Fatigue, congestion/runny nose, cough
Release 10 — day 42, dose 3
Symptoms: Sore throat, runny/congested nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release